Crude extracts of a multiply peptidase-deficient strain of Salmonella typhimurium contain an aminopeptidase that specifically removes N-terminal methionine from peptides. This activity shows pronounced specificity for the peptide's second amino acid. Methionine is removed from peptides with alanine, threonine, or glycine in this position but not when the second amino acid is leucine or methionine. The activity is stimulated by Co2l and is inhibited by EDTA.
Mutations that lead to overproduction (up to 30-fold) of the activity have been obtained by selecting for growth on MetGly-Gly as a methionine source. These mutations map at "3 map units, phage P22 cotransducible with leu. The overproducer mutations are dominant to wild type, and duplication of the wild-type allele of the locus leads to a gene dosage effect on peptidase levels. This suggests that the locus of the overproducer mutations may be the structural gene for the peptidase. NaDodSO4/PAGE shows an increased level of a single protein (34 kDa) in the overproducer mutant. This protein is highly enriched in a purified preparation of the peptidase. The specificity of this enzyme suggests that it is involved in the cleavage of methionine from newly synthesized peptide chains. This activity can specifically remove methionine from the N terminus of a completed protein. Treatment of purified, unprocessed (N-terminal methionine) interleukin 1p with the purified peptidase results in removal of N-terminal methionine with no additional alterations. N-terminal processing of at least this protein can occur after translation is complete. We propose to call this enzyme peptidase M (methionine-specific aminopeptidase).
Although all protein synthesis in bacteria is thought to initiate with N-formylmethionine, many mature proteins do not contain either N-formylmethionine or methionine at their N termini. Waller (1) showed that approximately half of the N-terminal amino acid from bulk Escherichia coli protein was not methionine. He noted that the distribution of N-terminal amino acids was highly nonrandom with alanine, serine, and threonine as the most frequent N termini after methionine. Sarimo and Pine (2) surveyed the distribution of N-terminal amino acids in the bulk protein of a variety of microbial species and concluded again that alanine, serine, and threonine compose most of the nonmethionine N termini. These experiments involved studies of bulk protein, and the results could have been skewed by the fact that only a few protein species make up a large fraction of the bulk protein of the cell (3) . More recent data allow the direct comparison of DNA sequences with protein amino acid sequences. Tsunasawa et al. (4) have surveyed the available sequences and concluded that N-terminal methionine may be removed when the second amino acid is alanine, glycine, proline, serine, threonine, or valine but never when it is arginine, asparagine, aspartic acid, glutamic acid, glutamine, isoleucine, leucine, lysine, or methionine. These data are consistent with proposals by the earlier authors that the nature of the second amino acid determines whether or not methionine will be removed. The available data suggest that the rules for methionine removal are the same in microorganisms and in higher cells (4) .
The pathway by which N termini are modified was defined by Adams (5) . He showed that E. coli extracts contain an enzyme that deformylates almost any N-formylmethionine peptide. No activity capable of directly cleaving N-forinylmethionine from an N-formylmethionine peptide was found. He concluded that N-terminal modification is a stepwise process, with deformylation preceding the removal of methionine by an aminopeptidase. Attempts to isolate this methionine-specific aminopeptidase have not been successful, however. Vogt (6) purified and characterized an activity capable of rapid cleavage of Met-Ala-Ser. He concluded that the specificity of this enzyme is not consistent with its involvement in N-terminal methionine removal. In addition, mutants of E. coli or Salmonella lacking this enzyme grow normally (7, 8) . Earlier reports of a ribosomal peptidase activity (9) almost certainly are based on the artifactual association of the enzyme described by Vogt with the ribosome fraction (6) . Another attempt to identify a methionine-specific aminopeptidase led to the isolation of an enzyme that appears to have specificity for methionine but hydrolyzes no substrates larger than dipeptides (10).
Clearly, a major problem in identifying a methioninespecific aminopeptidase in cell extracts is the presence of several broad-specificity enzymes capable of hydrolyzing N-terminal methionine peptides. We have shown that at least four such enzymes are present in crude extracts of Salmonella typhimurium and E. coli (7, 8, 11) . We have also isolated mutants that lack all of these activities and observed that these mutants, although greatly restricted in their capacity to use peptides as amino acid sources, still use certain Nterminal methionine peptides (8, 11) . This paper makes use of these mutant strains to identify a methionine-specific aminopeptidase and to isolate mutants that substantially overproduce this activity. The substrate specificity ofthis enzyme is entirely consistent with the proposal that it is involved in the removal of N-terminal methionine from newly synthesized proteins. 
MATERIALS AND METHODS
Bacterial Strains. The bacterial strains used in this work are all derivatives of S. typhimurium LT2 and are listed in Table 1 .
Media and Growth Conditions. Bacteriological media have been described (11) . When used as a methionine source, Met-Gly-Gly was present at 0.1 mM. Peptide utilization was tested as described (7) .
Genetic Techniques. Transduction with phage P22 HT 12/4 int-3 was carried out by using standard procedures (13) . Mutants able to use Met-Gly-Gly as a methionine source were selected by plating 0.1 ml of an overnight culture of TN2183 on an appropriately supplemented minimal plate containing Met-Gly-Gly as a methionine source. In some experiments a filter paper disc saturated with the mutagen diethyl sulfate was placed on the plate to increase the frequency of mutation.
Peptides. All peptides were obtained from commercial sources and were checked for homogeneity by HPLC. The composition and sequence of substrate peptides were confirmed by HPLC analysis of peptidase reaction products.
Peptidase Assay. The reaction mixture for assaying peptide hydrolysis contained 0.6 ,umol of substrate (usually Met-AlaSer), 0.03 ,mol of CoCl2, 6 ,umol of potassium phosphate buffer (pH 7.5), and enzyme in a total volume of 30 ,l. After incubation (30 min, 37°C) the reaction was stopped by adding 3 ,ul of 50% trichloroacetic acid, and precipitated protein was removed by centrifugation (5 minm Eppendorf centrifuge). An aliquot of the deproteinized reaction mixture was derivatized with trinitrobenzenesulfonic acid (Pierce) and analyzed by HPLC using an Altex Ultrasphere ODS column and appropriate gradients of 0.1% trifluoroacetic acid/H20-0.1% trifluoroacetic acid/acetonitrile. This procedure allows detection of all reaction products as well as the substrate peptide. One unit of activity hydrolyzes 1 ,mol of substrate per min. The assay was linear in time and protein.
Enzyme Purification. Strain TN2270 was grown in minimal glucose medium containing 0.4 mM leucine and 0.4 mM methionine. The cell pellet was suspended in 0.01 M potassium phosphate buffer (pH 7.5) and disrupted by sonication. After centrifugation, the supernatant was applied to a DEAEcellulose (Whatman DE-52) column equilibrated with the phosphate buffer (above) and eluted with a linear gradient of KCl to 0.4 M in the same buffer. The activity eluted at a salt concentration of 0.1 M. The active fractions were combined, concentrated over an ultrafiltration membrane (YM-10, Amicon), and passed through an Ultrogel AcA 54 column 
The methionine peptides were tested as methionine sources and the leucine peptides were tested as leucine sources.
(LKB) equilibrated in 0.05 M potassium phosphate buffer (pH 7.5). The activity eluted at a volume of 242 ml from a column with a void volume of 140 ml. The Met-Ala-Ser hydrolyzing fractions were combined and concentrated as above. The specific activity of this material was '13-fold higher than that of the starting extract and z290-fold higher than that of a wild-type extract. This material was further purified by chromatofocusing (Pharmacia PBE 94 in 0.025 M imidazole HCl, pH 7.4, eluted with Polybuffer 74 HCI, pH 4.0). The purified material from the peak fraction of this column was used for the experiment shown in Fig. 1 .
Preparation of N-Terminal Methionylated Human Interleukin 1p (IL-1p). Recombinant-produced IL-1p contains 20-25% unprocessed N-terminal methionine and was purified from E. coli as described (15) . The N-terminal methionylated and nonmethionylated forms of IL-1,3 were separated by chromatofocusing (22) . The separated proteins were precipitated with 3.2 M ammonium sulfate, resuspended with 50 mM sodium phosphate (pH 7.0), and then dialyzed against the same buffer. (Table 3) . In every case, only one peptide bond was hydrolyzed, yielding methionine as the only amino acid product. These extracts did not contain detectable activity toward Met-Leu-Gly, Met-MetAla, or Met-Met-Met but did hydrolyze Met-Gly-Gly at about 0.1 the rate of Met-Ala-Ser or Met-Ala-Met. The extracts also did not contain measurable activity toward several peptides with amino acids other than methionine at their N termini.
Unlike other Salmonella and E. coli peptidases (7, 8) , the activity could not be detected by activity stain after electrophoresis of crude extracts in nondenaturing PAGE gels (7).
Peptide hydrolysis was stimulated by Co2" but not by Mg2+, Mn +, or Zn2+ and was inhibited by EDTA (Table 4) . We propose to call this methionine-specific aminopeptidase peptidase M.
Isolation and Characterization of Mutants That Overproduce the Methionine-Specific Peptidase. The observation that Met-Gly-Gly does not support growth and is hydrolyzed by extracts at a slower rate than substrates with alanine as second amino acid suggested a method for isolating strains that overproduce peptidase M. When a methionine-requiring strain carrying nonreverting mutations in the genes specifying broad-specificity aminopeptidases (16) was plated on medium containing Met-Gly-Gly as a methionine source, mutants capable of using this peptide were obtained. Several of these mutants were purified and characterized. Although these mutant strains grew well on Met-Gly-Gly, they did not use Met-Leu-Gly, Met-Met-Ala, or Met-Met-Met nor did they grow on any of several N-terminal leucine peptides as leucine sources. Assays of peptide hydrolysis in an extract of one mutant, pepM100, showed a 20-to 30-fold increase in Met-Ala-Ser hydrolyzing activity. This strain was chosen for further characterization. The peptide use profile of a strain carrying pepM100 is compared to its parent in Table 2 . The data in Table 3 show that in an extract of the mutant strain, the levels of activity toward N-terminal methionine peptides with alanine, threonine, or glycine in the second position all show an A20-fold increase relative to the activity in a wild-type peptidase M strain. Met-Leu-Gly, Met-Met-Met, Met-Met-Ala, and several other peptides with N termini other than methionine are not hydrolyzed by either the mutant or parental extracts. The relative rates of hydrolysis for all substrate peptides are the same in the two extracts. These results suggest that the level of a single peptidase is increased by the pepM100 mutation and that this peptidase is specific for N-terminal methionine as well as for the peptide's second amino acid. The removal of N-terminal methionine from Met-Gly-Met-Met shows that the enzyme is capable of hydrolyzing tetrapeptides and is not limited in specificity to tripeptides. The mutant strain will not grow on any of several N-terminal methionine dipeptides (for example, Met-Gly and Met-Ala), and extracts will not hydrolyze these dipeptides (data not shown). We propose to call the locus that leads to overproduction pepM.
The map position of the mutations leading to overproduction of peptidase M has been determined. We first isolated an insertion of the minitransposon TnJOA16A17 (12) near the pepM locus (17) . This insertion was used to target the formation of an Hfr strain with an origin of transfer at the site of the TnJOA16AJ7 insertion (18) . Conjugation crosses using Hfr strains constructed in this way suggested that pepM is located in the 98-7 map unit region of the Salmonella genome 0.60 TN2565 (pepM+/pepM100) 0.77 Standard assays using Met-Ala-Ser as substrate were performed. (19) . Phage P22-mediated transduction crosses with markers in this region showed that pepM100 is linked -8% to leu at 3 map units. Other transposable elements linked to pepM were isolated and used as markers to further define the map position. Results ofthese crosses are shown in Table 5 . These results establish precisely the location of pepM and the transposable elements. Since all mutations leading to MetGly-Gly utilization tested are linked by P22 transduction to zae3149::TnJOA16A17, it is likely that they are all alleles of the pepM locus.
A strain containing a duplication of the pepM locus was constructed by the method of Anderson and Roth (20) using a TnJO insertion in the pyrA gene. This duplication strain was used for dominance testing and to see ifthere is a gene dosage effect on the levels of peptidase M. The presence ofpepM in the duplication was established by introducing pepM100 (by cotransduction with a linked transposon) into one side of the putative duplication and showing that the expected pattern of haploid segregants was observed. Enzyme levels in extracts of several duplication strains are shown in Table 6 . Clearly, the pepM100 mutation is dominant to pepM+. In addition, duplication of the wild-type pepM locus leads to increased levels of peptidase M. These results lead us to hypothesize that pepM is the structural gene for peptidase M. It seems reasonable to suppose that the mutations so far isolated affect a promoter or regulatory region of this gene.
Identification of the pepM Gene Product. Fig. 1 shows a NaDodSO4/PAGE gel of extracts from a pepM+ and a pepM100 strain. The level ofa protein of molecular mass =34 kDa reproducibly appears to be increased in the pepM100 strain. A preparation ofpeptidase M purified from a pepM100 strain (see Materials and Methods) shows substantial enrichment for this protein (Fig. 1) . It seems likely that this protein is peptidase M.
Enzymic (Fig. 2, lanes F and G) . All of the preparations of IL-1,9, treated and nontreated with enzyme, had identical molecular masses, as estimated by NaDodSO4/PAGE (data not shown), indicating that under the conditions used there had been no extensive N-terminal processing or internal cleavage of IL-1,0 proteins. N-terminal sequencing of proteins eluted from bands separated by isoelectric focusing indicated specific cleavage of methionine with no further processing of the authentic N terminus (alanine) (data not shown).
DISCUSSION
The properties of peptidase M are consistent with those expected for the aminopeptidase that removes N-terminal methionine from newly synthesized peptide chains. The enzyme is specific for N-terminal methionine, it shows a distinct preference for second amino acids that permit Nterminal methionine removal in vivo, and it is able to hydrolyze not only small peptides but also proteins with unprocessed N termini. Identification of this activity has been made possible by the previous isolation of mutants lacking other aminopeptidases that hydrolyze N-terminal methionine peptides in addition to other substrates. Peptidases A, N, B, and T will all hydrolyze Met-Ala-Ser, for example. Peptidase M appears to be a metallopeptidase, as are most of the other peptidases found in E. coli and Salmonella (21) .
The basis for selection of overproducer mutations is the observation that Met-Gly-Gly, although a substrate for the enzyme, is apparently not hydrolyzed sufficiently rapidly to allow its use as a methionine source. The availability of an overproducer of peptidase M provides a convenient source for purification of the enzyme. Overproduction of peptidase M does not seem to be deleterious to cell growth since strains containing the pepM100 overproducer mutation grow normally under all conditions we have tested. The enzyme seems to have very pronounced specificity for the second amino acid, making it unlikely that overproduction would result in removal of methionine from proteins that normally remain unmodified. The observation that purified peptidase M will remove N-terminal methionine from unprocessed IL-19 shows that, for at least one protein, N-terminal processing can take place after translation is complete and need not occur cotranslationally. In situations in which N-terminal processing is incomplete as a result of overproduction of a protein with a cleavable N-terminal sequence, in vivo (using overproducers of peptidase M) and in vitro (using the purified enzyme) approaches to generating cleaved product can be contemplated. However, the apparent rigid specificity of peptidase M for the second amino acid would seem to make this enzyme useless for removing N-terminal methionine from intrinsically resistant N termini.
It should be possible also to use the pepM mutations to isolate strains that produce less peptidase M than wild-type cells. It will be interesting to see what the phenotypic consequences of such mutations will be.
Note Added in Proof. We have now cloned the structural gene for peptidase M from S. typhimurium. This gene codes for a 264 amino acid protein that can be expressed in large amounts in both S. typhimurium and E. coli. We have shown that peptidase M will remove N-terminal methionine from two other recombinant proteins, interleukin 2 and granulocyte/macrophage colony-stimulating factor. An enzyme activity from E. coli similar to peptidase M has recently been reported by Ben-Bassat et al. (23) .
